1. AB0371 HYDROXYCHLOROQUINE AS VIEWED BY LUPUS PATIENTS – WHAT IMPACT FOR DOCTORS?. (2nd June 2020) Authors: Cornet, A.; Osmani, Z.; Frankel, S. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0311 The effect of b cell targeted therapies on autoantibodies and excessive neutrophil extracellular trap formation in systemic lupus erythematosus patients. (12th June 2018) Authors: Van Dam, L.S.; Osmani, Z.; Kraaij, T.; Kamerling, S.W.; Bakker, J.A.; Scherer, H.U.; Rabelink, T.J.; Voll, R.E.; Isenberg, D.; van Kooten, C.; Teng, Y.O. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0340 Dosage of hydroxychloroquine (PLAQUENIL) online survey by patient organisation nvle. (12th June 2018) Authors: Osmani, Z.; Zacouris-Verweij, W.; Otter, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0169 HYDROXYCHLOROQUINE PRESCRIPTION PATTERNS IN EUROPE - THE EUROPEAN SURVEY FOR LUPUS PATIENTS (ESLP). (2nd June 2020) Authors: Osmani, Z.; Cornet, A.; Zacouris-Verweij, W.; Frankel, S. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗